by Dale Harrison | Sep 14, 2022 | Press Releases
SAN ANTONIO–(BUSINESS WIRE)– bioAffinity Technologies, (NASDAQ: BIAF, BIAFW), a biotechnology company that develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung, today announced publication of its research in...
by Dale Harrison | Aug 17, 2022 | Publications
“Sputum analysis by flow cytometry; an effective platform to analyze the lung environment” PLoS ONE – August 17, 2022 Authors Bederka L.H., Sanchez JR, Rebeles J, Araujo PR, Grayson MH, Lai S-C, et al. Abstract Low-dose computed tomography...
by Dale Harrison | Jul 28, 2021 | Publications
“Quality-Controlled Sputum Analysis by Flow Cytometry” Journal of Visualized Experiments (JoVE) – August 9, 2021 Authors Marcia Grayson, Shao-Chiang Lai, Lydia H. Bederka, Patricia Araujo, Jamila Sanchez, Xavier T. Reveles, Vivienne I. Rebel,...
by Dale Harrison | Jul 2, 2021 | Publications
“Meso-tetra (4-carboMeso-tetra (4-carboxyphenyl) porphyrin (TCPP) is taken up in cancer cells by the CD320 receptor” International Conference on Porphyrins and Phthalocyanines (ICPP) ICPP-11, June 26 through July 2, 2021 Authors David J. Elzi, William E. Bauta,...
by Dale Harrison | Jun 25, 2021 | Publications
“Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors” RNA Therapeutics Institute’s 2021 RNA Therapeutics Symposium at the University of Massachusetts Medical School June 23 – 25, 2021 Authors David J. Elzi, William E. Bauta,...
